The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Designing Therapeutic Clinical Trials for Older and Frail Adults With Cancer: U13 Conference Recommendations
Open accessAbstract
A majority of cancer diagnoses and deaths occur in patients age ≥ 65 years. With the aging of the US population, the number of older adults with cancer will grow. Although the coming wave of older patients with cancer was anticipated in the early 1980s, when the need for more research on the cancer-aging interface was recognized, many knowledge gaps remain when it comes to treating older and/or frailer patients with cancer. Relatively little is known about the best way to balance the risks and benefits of existing cancer therapies in older patients; however, these patients continue to be underrepresented in clinical trials. Furthermore, the available clinical trials often do not include end points pertinent to the older adult population, such as preservation of function, cognition, and independence. As part of its ongoing effort to advance research in the field of geriatric oncology, the Cancer and Aging Research Group held a conference in November 2012 in collaboration with the National Cancer Institute, the National Institute on Aging, and the Alliance for Clinical Trials in Oncology. The goal was to develop recommendations and establish research guidelines for the design and implementation of therapeutic clinical trials for older and/or frail adults. The conference sought to identify knowledge gaps in cancer clinical trials for older adults and propose clinical trial designs to fill these gaps. The ultimate goal of this conference series is to develop research that will lead to evidence-based care for older and/or frail adults with cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Frailty in Older Adults: Evidence for a Phenotype
Fried, L. P., Tangen, C. M., Walston, J., Newman, A. B., Hirsch, C., Gottdiener, J., Seeman, T., Tracy, R., Kop, W. J., Burke, G., et al. (2001) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/56.3.m146 · Cited by 24,907
Frailty in relation to the accumulation of deficits
Rockwood, K., & Mitnitski, A. (2007) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/62.7.722 · Cited by 3,076
Underrepresentation of Patients 65 Years of Age or Older in Cancer-Treatment Trials
Hutchins, L. F., Unger, J. M., Crowley, J. J., Coltman, C. A., & Albain, K. S. (1999) · New England Journal of Medicine · doi:10.1056/nejm199912303412706 · Cited by 2,174
Predicting chemotherapy toxicity in older adults with cancer: a prospective multicenter study
Hurria, A., Togawa, K., Mohile, S. G., Owusu, C., Klepin, H. D., Gross, C. P., Lichtman, S. M., Gajra, A., Bhatia, S., Katheria, V., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.34.7625 · Cited by 1,841 · cited 3×
“Recent research studies are starting to provide an evidence-based definition.(21,22) Marker-by-treatment interaction design.”
BackgroundMethodSelf-citationFuture of Cancer Incidence in the United States: Burdens Upon an Aging, Changing Nation
Smith, B. D., Smith, G. L., Hurria, A., Hortobagyi, G. N., & Buchholz, T. A. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.20.8983 · Cited by 1,721
Self-citationWalston, J., Hadley, E. C., Ferrucci, L., Guralnik, J. M., Newman, A. B., Studenski, S. A., Ershler, W. B., Harris, T., & Fried, L. P. (2006) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2006.00745.x · Cited by 1,605 · cited 1×
“This is distinct from, although may overlap with, the geriatrician’s definition of frailty, which is a vulnerable health condition resulting in a decreased ability to respond to a stressor that is associated with a higher likelihood of functional decline, disability, hospitalization, and mortality.(33,34) Two well-est…”
BackgroundUnderstanding the Treatment Preferences of Seriously Ill Patients
Fried, T. R., Bradley, E. H., Towle, V. R., & Allore, H. (2002) · New England Journal of Medicine · doi:10.1056/nejmsa012528 · Cited by 1,522
Age and acute myeloid leukemia
Appelbaum, F. R., Gundacker, H., Head, D. R., Slovak, M. L., Willman, C. L., Godwin, J. E., Anderson, J. E., & Petersdorf, S. H. (2006) · Blood · doi:10.1182/blood-2005-09-3724 · Cited by 1,350
Extermann, M., Boler, I., Reich, R. R., Lyman, G. H., Brown, R. H., DeFelice, J., Levine, R. M., Lubiner, E. T., Reyes, P., Schreiber, F. J., et al. (2012) · Cancer · doi:10.1002/cncr.26646 · Cited by 1,143
Self-citationJuliusson, G., Antunovic, P., Derolf, Å., Lehmann, S., Möllgård, L., Stockelberg, D., Tidefelt, U., Wahlin, A., & Höglund, M. (2009) · Blood · doi:10.1182/blood-2008-07-172007 · Cited by 987
Talarico, L., Chen, G., & Pazdur, R. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.02.175 · Cited by 727
de Moor, J. S., Mariotto, A. B., Parry, C., Alfano, C. M., Padgett, L., Kent, E. E., Forsythe, L., Scoppa, S., Hachey, M., & Rowland, J. H. (2013) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-12-1356 · Cited by 670 · cited 1×
“7 million in 2012, and this number is expected to reach 18 million in the next 10 years.(61) Approximately 60% of today’s cancer survivors are age 65 years,(3) and this number will steadily increase because of an overall rise in life expectancy and advances in early detection and cancer treatment.”
BackgroundSelf-citationLara, P. N., Higdon, R., Lim, N., Kwan, K., Tanaka, M., Lau, D. H. M., Wun, T., Welborn, J., Meyers, F. J., Christensen, S., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.6.1728 · Cited by 588
Systematic Review of Barriers to the Recruitment of Older Patients With Cancer Onto Clinical Trials
Townsley, C. A., Selby, R., & Siu, L. L. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.00.141 · Cited by 583
Leith, C. P., Kopecky, K. J., Chen, I. M., Eijdems, L., Slovak, M. L., McConnell, T. S., Head, D. R., Weick, J. K., Grever, M. R., Appelbaum, F. R., et al. (1999) · PubMed · doi:10.1182/blood.v94.3.1086.415k32_1086_1099 · Cited by 573
Adjuvant Chemotherapy in Older Women with Early-Stage Breast Cancer
Muss, H. B., Berry, D. A., Cirrincione, C. T., Theodoulou, M., Mauer, A. M., Kornblith, A. B., Partridge, A. H., Dressler, L. G., Cohen, H. J., Becker, H. P., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810266 · Cited by 554
Self-citationUndertreatment Strongly Decreases Prognosis of Breast Cancer in Elderly Women
Bouchardy, C., Rapiti, E., Fioretta, G., Laissue, P., Neyroud-Caspar, I., Schäfer, P., Kurtz, J., Sappino, A.-P., & Vlastos, G. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.02.046 · Cited by 512
Age and Adjuvant Chemotherapy Use After Surgery for Stage III Colon Cancer
Schrag, D., Cramer, L. D., Bach, P. B., & Begg, C. B. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.11.850 · Cited by 481
Barriers to Clinical Trial Participation by Older Women With Breast Cancer
Kemeny, M. M., Peterson, B. L., Kornblith, A. B., Muss, H. B., Wheeler, J., Levine, E., Bartlett, N., Fleming, G., & Cohen, H. J. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.09.124 · Cited by 465
Self-citationCancer survivors: a booming population
Parry, C., Kent, E. E., Mariotto, A. B., Alfano, C. M., & Rowland, J. H. (2011) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-11-0729 · Cited by 456
Self-citationUnder-Representation of Older Adults in Cancer Registration Trials: Known Problem, Little Progress
Scher, K. S., & Hurria, A. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2012.41.6727 · Cited by 432
Self-citationSeymour, M. T., Thompson, L. C., Wasan, H. S., Middleton, G., Brewster, A. E., Shepherd, S. F., O'Mahony, M. S., Maughan, T. S., Parmar, M., & Langley, R. E. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60399-1 · Cited by 419
Public Attitudes Toward Participation in Cancer Clinical Trials
Comis, R. L., Miller, J. D., Aldigé, C. R., Krebs, L., & Stoval, E. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.02.105 · Cited by 393
Representation of older patients in cancer treatment trials
Trimble, E. L., Cain, D., Ungerleider, R. S., Friedman, M. A., Carter, C. L., & Freidlin, B. (1994) · Cancer · doi:10.1002/1097-0142(19941001)74:7+<2208::aid-cncr2820741737>3.0.co;2-# · Cited by 343
Use of Geriatric Assessment for Older Adults in the Oncology Setting: A Systematic Review
Puts, M. T. E., Hardt, J., Monette, J., Girre, V., Springall, E., & Alibhai, S. M. H. (2012) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djs285 · Cited by 335
The Geriatric Emergency Department
Hwang, U., & Morrison, R. S. (2007) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2007.01400.x · Cited by 321
Enrollment of Older Patients in Cancer Treatment Trials in Canada: Why is Age a Barrier?
Yee, K. W. L., Pater, J. L., Pho, L., Zee, B., & Siu, L. L. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.12.044 · Cited by 304
Fröhling, S., Schlenk, R. F., Kayser, S., Morhardt, M., Benner, A., Döhner, K., Döhner, H., & for the German-Austrian AML Study Group (2006) · Blood · doi:10.1182/blood-2006-04-014324 · Cited by 300
Multiple Cancer Prevalence: A Growing Challenge in Long-term Survivorship
Mariotto, A. B., Rowland, J. H., Ries, L. A. G., Scoppa, S., & Feuer, E. J. (2007) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-06-0782 · Cited by 283
Self-citationAparicio, T., Jouve, J.-L., Teillet, L., Gargot, D., Subtil, F., Le Brun-Ly, V., Cretin, J., Locher, C., Bouché, O., Breysacher, G., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.42.9894 · Cited by 216
Provider roles in the recruitment of underrepresented populations to cancer clinical trials
Howerton, M. W., Gibbons, M. C., Baffi, C. R., Gary, T. L., Lai, G. Y., Bolen, S., Tilburt, J., Tanpitukpongse, T. P., Wilson, R. F., Powe, N. R., et al. (2007) · Cancer · doi:10.1002/cncr.22436 · Cited by 184
Differences in initial treatment patterns and outcomes of lung cancer in the elderly
Smith, T. J., Penberthy, L., Desch, C. E., Whittemore, M., Newschaffer, C., Hillner, B. E., McClish, D., & Retchin, S. M. (1995) · Lung Cancer · doi:10.1016/0169-5002(95)00496-3 · Cited by 172
Kennedy, B. J. (1988) · Journal of Clinical Oncology · doi:10.1200/jco.1988.6.12.1903 · Cited by 160
Wildes, T. M., Ruwe, A. P., Fournier, C., Gao, F., Carson, K. R., Piccirillo, J. F., Tan, B. R., & Colditz, G. A. (2013) · Journal of Geriatric Oncology · doi:10.1016/j.jgo.2013.02.002 · Cited by 131
Biological, Clinical, and Psychosocial Correlates at the Interface of Cancer and Aging Research
Dale, W., Mohile, S. G., Eldadah, B. A., Trimble, E. L., Schilsky, R. L., Cohen, H. J., Muss, H. B., Schmader, K. E., FERRELL, B. R., Extermann, M., et al. (2012) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djs145 · Cited by 122
Self-citationHurria, A., Wong, F. L., Villaluna, D., Bhatia, R., Chung, C. T., Mortimer, J. E., Hurvitz, S. A., & Naeim, A. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.17.6891 · Cited by 119
Self-citationDeMichele, A. M., Putt, M., Zhang, Y., Glick, J. H., & Norman, S. A. (2003) · Cancer · doi:10.1002/cncr.11338 · Cited by 106
Challenges of Recruitment and Retention in Multisite Clinical Research
Cooley, M. E., Sarna, L., Brown, J. K., Williams, R. D., Chernecky, C. C., PADILLA, G. V., & Danao, L. L. (2003) · Cancer Nursing · doi:10.1097/00002820-200310000-00006 · Cited by 97
Lichtman, S. M., Hollis, D. R., Miller, A. A., Rosner, G. L., Rhoades, C. A., Lester, E. P., Millard, F. E., Byrd, J. C., Cullinan, S. A., Rosen, D. M., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.9289 · Cited by 97
Ramjaun, A., Nassif, M. O., Krotneva, S., Huang, A. R., & Meguerditchian, A. N. (2013) · Journal of Geriatric Oncology · doi:10.1016/j.jgo.2013.04.002 · Cited by 96
Spaar, A., Frey, M., Turk, A. J., Karrer, W. L., & Puhan, M. A. (2009) · BMC Medical Research Methodology · doi:10.1186/1471-2288-9-14 · Cited by 93
Research Priorities in Geriatric Oncology: Addressing the Needs of an Aging Population
Hurria, A., Mohile, S. G., & Dale, W. (2012) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2012.0025 · Cited by 90
Self-citationGeriatric oncology research to improve clinical care
Mohile, S. G., Dale, W., & Hurria, A. (2012) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2012.125 · Cited by 89
Self-citationMandelblatt, J. S., Sheppard, V. B., Hurria, A., Kimmick, G. G., Isaacs, C. J., Taylor, K. L., Kornblith, A. B., Noone, A., Luta, G., Tallarico, M., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.24.3295 · Cited by 84
Self-citationGross, C. P., Herrin, J. S., Wong, N. S. M., & Krumholz, H. M. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.14.365 · Cited by 82
Barriers to Enrollment of Elderly Adults in Early-Phase Cancer Clinical Trials
Basche, M., Barón, A. E., Eckhardt, S., Balducci, L., Persky, M. S., Levin, A. R., Jackson, N., Zeng, C. X., Vranas, P., & Steiner, J. F. (2008) · Journal of Oncology Practice · doi:10.1200/jop.0842001 · Cited by 72
Penberthy, L. T., Brown, R., Wilson-Genderson, M., Dahman, B. A., Ginder, G. D., & Siminoff, L. A. (2012) · Clinical Trials · doi:10.1177/1740774512458992 · Cited by 64
Kennedy, B. J. (2000) · PubMed · Cited by 47
Houterman, S., Janssen-Heijnen, M. L. G., Verheij, C. D. G. W., et al. (2006) · Prostate Cancer and Prostatic Diseases · doi:10.1038/sj.pcan.4500868 · Cited by 45
Variability in the Treatment of Elderly Patients with Stage IIIA (N2) Non–Small-Cell Lung Cancer
Berry, M. F., Worni, M., Pietrobon, R. S., D’Amico, T. A., & Akushevich, I. V. (2013) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31828916aa · Cited by 41
Cancer Trial Enrollment After State-Mandated Reimbursement
Gross, C. P., Murthy, V., Li, Y., Kaluzny, A. D., & Krumholz, H. M. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh193 · Cited by 41
Identifying Barriers Associated With Enrollment of Patients With Lung Cancer into Clinical Trials
Horn, L., Keedy, V. L., Campbell, N., y García, G. G., Hayes, A., Spencer, B., Carbone, D. P., Sandler, A. B., & Johnson, D. H. (2012) · Clinical Lung Cancer · doi:10.1016/j.cllc.2012.03.008 · Cited by 34
Enrollment of Older Persons in Cancer Trials After the Medicare Reimbursement Policy Change
Gross, C. P., Wong, N. S. M., Dubin, J. A., Mayne, S. T., & Krumholz, H. M. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.13.1514 · Cited by 30
Extermann, M., & Wedding, U. (2011) · Journal of Geriatric Oncology · doi:10.1016/j.jgo.2011.11.004 · Cited by 27
Self-citation
Cited by
Management of frailty: opportunities, challenges, and future directions
Dent, E., Martin, F. C., Bergman, H., Woo, J., Romero-Ortuno, R., & Walston, J. D. (2019) · The Lancet · doi:10.1016/s0140-6736(19)31785-4 · Cited by 1,678
Mohile, S. G., Dale, W., Somerfield, M. R., Schonberg, M. A., Boyd, C. M., Burhenn, P. S., Canin, B., Cohen, H. J., Holmes, H. M., Hopkins, J. O., et al. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2018.78.8687 · Cited by 1,479
Self-citationA review of cancer immunotherapy toxicity
Kennedy, L. B., & Salama, A. K. S. (2020) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21596 · Cited by 1,364
Kim, E. S., Bruinooge, S. S., Roberts, S., Ison, G., Lin, N. U., Gore, L., Uldrick, T. S., Lichtman, S. M., Roach, N., Beaver, J. A., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2017.73.7916 · Cited by 485
Self-citationSedrak, M. S., Freedman, R. A., Cohen, H. J., Muss, H. B., Jatoi, A., Klepin, H. D., Wildes, T. M., Le‐Rademacher, J. G., Kimmick, G. G., Tew, W. P., et al. (2021) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21638 · Cited by 471
Self-citation
Metadata
- Authors
- Hurria, A., Dale, W., Mooney, M., Rowland, J. H., Ballman, K. V., Cohen, H. J., Muss, H. B., Schilsky, R. L., Ferrell, B., Extermann, M., Schmader, K. E., & Mohile, S. G.
- Venue
- Journal of Clinical Oncology
- Published
- 2014-08-20
- Volume
- 32
- Issue
- 24
- Pages
- 2587-2594
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2159296014
- Cited by
- 362
- References
- 54
- FWCI
- 11.00
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.